PTC Therapeutics
PTCT
PTCT
171 hedge funds and large institutions have $2.37B invested in PTC Therapeutics in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 71 increasing their positions, 55 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
171
Holders Change
-6
Holders Change %
-3.39%
% of All Funds
2.51%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
26
Increased
71
Reduced
55
Closed
29
Calls
$11.8M
Puts
$3.38M
Net Calls
+$8.4M
Net Calls Change
+$10.7M
Top Buyers
| 1 |
CAC
Cowen and Company
New York
|
$103M |
| 2 |
Morgan Stanley
New York
|
$68.7M |
| 3 |
State Street
Boston,
Massachusetts
|
$128M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
$24.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$243M |
